Evidence map›Paper›PMID 25644607›Full record

Observational studyCancer medicine2015

Sequential occurrence of dyspnea at the end of life in palliative care, according to the underlying cancer.

Frédéric Guirimand, Marine Sahut d'izarn, Lucy Laporte, Marie Francillard, Jean-François Richard, Philippe Aegerter

Abstract readObservational Study
In one paragraph

Observational study in Cancer medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Trial
  2. Article
  3. Management of dyspnea in palliative care.Current oncology (Toronto, Ont.) · 2020
    Article
  4. Symptoms of and Palliative Treatment for Unresectable Skin Cancer.Current treatment options in oncology · 2019
    Review
  5. Review
  6. Article
  7. Impact of dyspnea on advanced cancer patients referred to a palliative radiotherapy clinic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Frédéric GuirimandPôle Recherche SPES ("Soins Palliatifs En Société"), Maison Médicale Jeanne Garnier, Paris, 75015, France.
Marine Sahut d'izarn
Lucy Laporte
Marie Francillard
Jean-François Richard
Philippe Aegerter

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyspnea is a symptom that severely affects the quality of life of terminally ill patients. Its frequency differs considerably between studies. We aimed to characterize the frequency of dyspnea in a palliative care hospital (PCH) and to identify factors predisposing to dyspnea, particularly during the very last days of life, as a function of the underlying disease. Episodes of dyspnea were identified by the computerized extraction of prospectively collected data from the reports of care assistants or from medical observations recorded in the medical files for all stays at our PCH during the last 6 years. There were 6455 hospital stays, 88% ending in the death of the patient; 13,282 episodes of dyspnea were recorded during 2608 hospital stays (40%). Dyspnea was more frequently observed in cases of cancer than in other conditions (RR = 1.30; 95% CI: 1.14-1.48). Pulmonary metastasis increased the risk of dyspnea from 37% to 51% (RR = 1.37; 95% CI: 1.29-1.46). Dyspnea frequency varied with the primary cancer site, from 24% (brain cancer) to 60% (esophageal cancer). The data for cancer patients staying for more than 6 days who subsequently died indicated that 8% of patients experienced dyspnea exclusively during the last 4 days of the life, independently of the site of the primary cancer. Dyspnea during the last few days of life requires systematic assessment. Exclusively terminal dyspnea should be distinguished from more precocious dyspnea, as the pathophysiological mechanisms and treatments of these two forms are probably different.

Indexed as

AgedDyspneaFemaleHumansLength of StayLung NeoplasmsMaleNeoplasmsPalliative CareRetrospective StudiesRisk FactorsTerminal CareCancerdyspneapalliative carepalliative care hospitalsupportive care

Identifiers

PMID25644607
PMCPMC4402068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.